Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Net Income towards Common Stockholders (2016 - 2025)

INVO Fertility (IVF) has disclosed Net Income towards Common Stockholders for 15 consecutive years, with -$2.6 million as the latest value for Q3 2025.

  • Quarterly Net Income towards Common Stockholders fell 62.18% to -$2.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$29.2 million through Sep 2025, down 291.1% year-over-year, with the annual reading at -$9.3 million for FY2024, 16.33% down from the prior year.
  • Net Income towards Common Stockholders for Q3 2025 was -$2.6 million at INVO Fertility, up from -$5.3 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $101782.0 in Q4 2021, with the low at -$17.4 million in Q1 2025.
  • Average Net Income towards Common Stockholders over 5 years is -$3.2 million, with a median of -$2.5 million recorded in 2021.
  • The sharpest move saw Net Income towards Common Stockholders skyrocketed 102.67% in 2021, then crashed 2818.59% in 2022.
  • Over 5 years, Net Income towards Common Stockholders stood at $101782.0 in 2021, then plummeted by 2818.59% to -$2.8 million in 2022, then rose by 27.88% to -$2.0 million in 2023, then plummeted by 94.13% to -$3.9 million in 2024, then soared by 31.74% to -$2.6 million in 2025.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at -$2.6 million, -$5.3 million, and -$17.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.